News

Get in touch

Remynd is located in the Arenberg Science Park, a hub of innovation and research. Our labs and offices are situated in the Bio Incubator 3 building.

Press releases & papers

3 Apr 2025

AI-powered digital twins help interpret early signals in a small Phase 2a study of a novel therapy for Alzheimer’s Disease

4 Mar 2025

remynd strenghtens drug development focus with strategic sale of CRO business to InnoSer

3 Jul 2024

remynd announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease

9 Mar 2024

remynd appoints new CEO and Chairman to progress novel Alzheimer’s Disease program through clinical development

5 Aug 2024

Pharmacological modulation of septins